The ginsenoside metabolite compound K inhibits growth, migration and stemness of glioblastoma cells

International Journal of Oncology

Volumn 51, Issue 2, 2017, Pages 414-424

  Lee, Sanghun ^a   Kwon, Min Cheol ^b   Jang, Jun Pil ^b   Sohng, Jae Kyung ^a   Jung, Hye Jin ^a  

^a SunMoon University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Anticancer effect; Compound K; Ginsenoside; Glioblastoma; Glioblastoma stem like cells

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 9; CD133 ANTIGEN; CYCLIN D1; CYCLIN D3; GINSENOSIDE; MAMMALIAN TARGET OF RAPAMYCIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; OCTAMER TRANSCRIPTION FACTOR 4; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; GINSENOSIDE M1; TUMOR PROTEIN;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL INVASION; CONTROLLED STUDY; G1 PHASE CELL CYCLE CHECKPOINT; GLIOBLASTOMA CELL LINE; GLIOMA STEM CELL; HUMAN; HUMAN CELL; METASTASIS INHIBITION; MIGRATION INHIBITION; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; STEM CELL SELF-RENEWAL; CANCER STEM CELL; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; GLIOBLASTOMA; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GINSENOSIDES; GLIOBLASTOMA; HUMANS; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION;

EID: 85021817397     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2017.4054     Document Type: Article

References (50)

1. Pazhouhi M, Sariri R, Rabzia A and Khazaei M: Thymoquinone synergistically potentiates temozolomide cytotoxicity through the inhibition of autophagy in U87MG cell line. Iran J Basic Med Sci 19: 890-898, 2016.
2. Bak DH, Kang SH, Choi D.R., Gil MN, Yu KS, Jeong JH, Lee N.S., Lee JH, Jeong YG, Kim DK, et al.: Autophagy enhancement contributes to the synergistic effect of vitamin D in temo-zolomide-based glioblastoma chemotherapy. Exp Ther Med 11: 2153-2162, 2016.
3. Safari M and Khoshnevisan A: Cancer stem cells and chemo-resistance in glioblastoma multiform: A review article. J Stem Cells 10: 271-285, 2015.
4. Stupp R, Mason W P, Van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al.; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005.
5. Park D and Yoon M: Compound K, a novel ginsenoside metabolite, inhibits adipocyte differentiation in 3T3-L1 cells: Involvement of angiogenesis and MMPs. Biochem Biophys Res Commun 422: 263-267, 2012.
6. Attele AS, Wu JA and Yuan CS: Ginseng pharmacology: Multiple constituents and multiple actions. Biochem Pharmacol 58: 1685-1693, 1999.
7. Cho CW, Kim YC, Kang J.H., Rhee YK, Choi SY, Kim KT, Lee YC and Hong HD: Characteristic study on the chemical components of Korean curved ginseng products. J Ginseng Res 37: 349-354, 2013.
8. Guo J, Chang L, Zhang X., Pei S, Yu M and Gao J: Ginsenoside compound K promotes β-amyloid peptide clearance in primary astrocytes via autophagy enhancement. Exp Ther Med 8: 1271-1274, 2014.
9. Qi LW, Wang CZ, Du G.J., Zhang ZY, Calway T and Yuan CS: Metabolism of ginseng and its interactions with drugs. Curr Drug Metab 12: 818-822, 2011.
10. Li W, Zhang M, Gu J., Meng ZJ, Zhao LC, Zheng YN, Chen L and Yang GL: Hypoglycemic effect of protopanaxadiol-type ginsenosides and compound K on Type 2 diabetes mice induced by high-fat diet combining with streptozotocin via suppression of hepatic gluconeogenesis. Fitoterapia 83: 192-198, 2012.
11. Kim DY, Yuan HD, Chung IK and Chung SH: Compound K, intestinal metabolite of ginsenoside, attenuates hepatic lipid accumulation via AMPK activation in human hepatoma cells. J Agric Food Chem 57: 1532-1537, 2009.
12. Kim K, Park M, Lee Y.M., Rhyu MR and Kim HY: Ginsenoside metabolite compound K stimulates glucagon-like peptide-1 secretion in NCI-H716 cells via bile acid receptor activation. Arch Pharm Res 37: 1193-1200, 2014.
13. Akao T, Kanaoka M and Kobashi K: Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administration - measurement of compound K by enzyme immunoassay. Biol Pharm Bull 21: 245-249, 1998.
14. Shin KO, Seo CH, Cho H.H., Oh S., Hong SP, Yoo HS, Hong JT, Oh KW and Lee YM: Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells. Arch Pharm Res 37: 1183-1192, 2014.
15. Hasegawa H, Sung JH and Huh JH: Ginseng intestinal bacterial metabolite IH901 as a new anti-metastatic agent. Arch Pharm Res 20: 539-544, 1997.
16. Zhang K and Li Y: Effects of ginsenoside compound K combined with cisplatin on the proliferation, apoptosis and epithelial mesenchymal transition in MCF-7 cells of human breast cancer. Pharm Biol 54: 561-568, 2016.
17. Kang KA, Piao MJ, Kim K.C., Zheng J., Yao CW, Cha JW, Kim HS, Kim D.H., Bae SC and Hyun JW: Compound K, a metabolite of ginseng saponin, inhibits colorectal cancer cell growth and induces apoptosis through inhibition of histone deacetylase activity. Int J Oncol 43: 1907-1914, 2013.
18. Zhang Z, Du GJ, Wang C.Z., Wen XD, Calway T, Li Z, He T.C., Du W., Bissonnette M, Musch MW, et al.: Compound K, a ginsenoside metabolite, inhibits colon cancer growth via multiple pathways including p53-p21 interactions. Int J Mol Sci 14: 2980-2995, 2013.
19. Zheng ZZ, Ming YL, Chen L.H., Zheng GH, Liu SS and Chen QX: Compound K-induced apoptosis of human hepatocellular carcinoma MHCC97-H cells in vitro. Oncol Rep 32: 325-331, 2014.
20. Aroui S, Aouey B, Chtourou Y., Meunier AC, Fetoui H and Kenani A: Naringin suppresses cell metastasis and the expression of matrix metalloproteinases (MMP-2 and MMP-9) via the inhibition of ERK-P38-JNK signaling pathway in human glioblastoma. Chem Biol Interact 244: 195-203, 2016.
21. Zou M, Zhang X and Xu C: IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3, 3'-diindolyl-methane in ovarian cancer cells. Cell Oncol (Dordr) 39: 47-57, 2016.
22. Yang N, Hui L, Wang Y., Yang H and Jiang X: SOX2 promotes the migration and invasion of laryngeal cancer cells by induction of MMP-2 via the PI3K/Akt/mTOR pathway. Oncol Rep 31: 2651-2659, 2014.
23. Chen BB, Glasser Jr, Coon TA and Mallampalli RK: F-box protein FBXL2 exerts human lung tumor suppressor-like activity by ubiquitin-mediated degradation of cyclin D3 resulting in cell cycle arrest. Oncogene 31: 2566-2579, 2012.
24. Lin JT, Li HY, Chang N.S., Lin CH, Chen YC and Lu PJ: WWOX suppresses prostate cancer cell progression through cyclin D1-mediated cell cycle arrest in the G1 phase. Cell Cycle 14: 408-416, 2015.
25. Qian C, Wang JQ, Song C.L., Wang LL, Ji LN and Chao H: The induction of mitochondria-mediated apoptosis in cancer cells by ruthenium(II) asymmetric complexes. Metallomics 5: 844-854, 2013.
26. Chou YC, Chang MY, Wang M.J., Harnod T., Hung CH, Lee HT, Shen CC and Chung JG: PEITC induces apoptosis of Human Brain Glioblastoma GBM8401 Cells through the extrinsic- and intrinsic signaling pathways. Neurochem Int 81: 32-40, 2015.
27. Ray T, Chakrabarti MK and Pal A: Hemagglutinin protease secreted by V. cholerae induced apoptosis in breast cancer cells by ROS mediated intrinsic pathway and regresses tumor growth in mice model. Apoptosis 21: 143-154, 2016.
28. Liu Y, Jiao R, Ma Z.G., Liu W., Wu QQ, Yang Z, Li FF, Yuan Y, Bian ZY and Tang QZ: Sanguinarine inhibits angiotensin II-induced apoptosis in H9c2 cardiac cells via restoring reactive oxygen species-mediated decreases in the mitochondrial membrane potential. Mol Med Rep 12: 3400-3408, 2015.
29. Yu XS, Du J, Fan Y.J., Liu FJ, Cao LL, Liang N, Xu DG and Zhang JD: Activation of endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance of human small cell lung cancer cells by inhibiting the PI3K/AKT/mTOR signaling pathway. Oncotarget 7: 76827-76839, 2016.
30. Bischof J, Westhoff MA, Wagner J.E., Halatsch ME, Trentmann S, Knippschild U, Wirtz CR and Burster T: Cancer stem cells: The potential role of autophagy, proteolysis, and cathepsins in glio-blastoma stem cells. Tumour Biol 39: 1010428317692227, 2017.
31. Jung EH, Lee HN, Han G.Y., Kim MJ and Kim CW: Targeting ROR1 inhibits the self-renewal and invasive ability of glio-blastoma stem cells. Cell Biochem Funct 34: 149-157, 2016.
32. Guo Y, Liu S, Wang P., Zhao S, Wang F, Bing L., Zhang Y, Ling EA, Gao J and Hao A: Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas. Histopathology 59: 763-775, 2011.
33. Kim H, Roh HS, Kim J.E., Park SD, Park WH and Moon JY: Compound K attenuates stromal cell-derived growth factor 1 (SDF-1)-induced migration of C6 glioma cells. Nutr Res Pract 10: 259-264, 2016.
34. 2 inhibit tumor necrosis factor-alpha-induced activation of the NF-kappaB and JNK pathways in human astroglial cells. Neurosci Lett 421: 37-41, 2007.
35. Yang XD, Yang YY, Ouyang DS and Yang GP: A review of biotransformation and pharmacology of ginsenoside compound K. Fitoterapia 100: 208-220, 2015.
36. Gutschalk CM, Yanamandra AK, Linde N, Meides A., Depner S and Mueller MM: GM-CSF enhances tumor invasion by elevated MMP-2, -9, and -26 expression. Cancer Med 2: 117-129, 2013.
37. Kalhori V and Törnquist K: MMP2 and MMP9 participate in S1P-induced invasion of follicular ML-1 thyroid cancer cells. Mol Cell Endocrinol 404: 113-122, 2015.
38. Chou YC, Chang MY, Wang M.J., Yu FS, Liu HC, Harnod T, Hung C.H., Lee HT and Chung JG: PEITC inhibits human brain glioblastoma GBM 8401 cell migration and invasion through the inhibition of uPA, Rho A, and Ras with inhibition of MMP-2, -7 and -9 gene expression. Oncol Rep 34: 2489-2496, 2015.
39. Lathia JD, Mack SC, Mulkearns-Hubert EE, Valentim CL and Rich JN: Cancer stem cells in glioblastoma. Genes Dev 29: 1203-1217, 2015.
40. Cho DY, Lin SZ, Yang W.K., Lee HC, Hsu DM, Lin HL, Chen C.C., Liu CL, Lee WY and Ho LH: Targeting cancer stem cells for treatment of glioblastoma multiforme. Cell Transplant 22: 731-739, 2013.
41. Cruceru ML, Neagu M, Demoulin JB and Constantinescu SN: Therapy targets in glioblastoma and cancer stem cells: Lessons from haematopoietic neoplasms. J Cell Mol Med 17: 1218-1235, 2013.
42. Gatti M, Pattarozzi A, Bajetto A., Würth R, Daga A., Fiaschi P, Zona G, Florio T and Barbieri F: Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity. Toxicology 314: 209-220, 2013.
43. Ashizawa T, Miyata H, Iizuka A., Komiyama M, Oshita C, Kume A., Nogami M, Yagoto M, Ito I., Oishi T, et al.: Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma. Int J Oncol 43: 219-227, 2013.
44. Kim B, Jung N, Lee S., Sohng JK and Jung HJ: Apigenin inhibits cancer stem cell-like phenotypes in human glioblastoma cells via suppression of c-Met signaling. Phytother Res 30: 1833-1840, 2016.
45. Safa AR, Saadatzadeh MR, Cohen-Gadol AA, Pollok KE and Bijangi-Vishehsaraei K: Emerging targets for glioblastoma stem cell therapy. J Biomed Res 30: 19-31, 2015.
46. Oh J and Kim JS: Compound K derived from ginseng: Neuroprotection and cognitive improvement. Food Funct 7: 4506-4515, 2016.
47. Ye R, Zhang X, Kong X., Han J, Yang Q, Zhang Y., Chen Y, Li P, Liu J., Shi M, et al.: Ginsenoside Rd attenuates mitochondrial dysfunction and sequential apoptosis after transient focal ischemia. Neuroscience 178: 169-180, 2011.
48. Kang KA, Kim HS, Kim DH and Hyun JW: The role of a ginseng saponin metabolite as a DNA methyltransferase inhibitor in colorectal cancer cells. Int J Oncol 43: 228-236, 2013.
49. Dougherty U, Mustafi R, Wang Y., Musch MW, Wang CZ, Konda VJ, Kulkarni A, Hart J., Dawson G, Kim KE, et al.: American ginseng suppresses Western diet-promoted tumori-genesis in model of inflammation-associated colon cancer: Role of EGFR. BMC Complement Altern Med 11: 111, 2011.
50. Choi HH, Jong HS, Park J.H., Choi S., Lee J W, Kim TY, Otsuki T, Namba M and Bang YJ: A novel ginseng saponin metabolite induces apoptosis and down-regulates fibroblast growth factor receptor 3 in myeloma cells. Int J Oncol 23: 1087-1093, 2003.